1 Market Overview
1.1 Anti-Obesity Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Centrally Acting Anti-obesity Drugs
1.2.2 Peripherally Acting Anti-obesity Drugs
1.3 Market Analysis by Application
1.3.1 Hospital Use
1.3.2 Clinic Use
1.3.3 Household
1.3.4 Other
1.4 Market Analysis by Region
1.4.1 United States Market States and Outlook (2015-2028)
1.4.2 Europe Market States and Outlook (2015-2028)
1.4.3 China Market States and Outlook (2015-2028)
1.4.4 Japan Market States and Outlook (2015-2028)
1.4.5 Southeast Asia Market States and Outlook (2015-2028)
1.4.6 India Market States and Outlook (2015-2028)
1.4.7 Brazil Market States and Outlook (2015-2028)
1.4.8 GCC Countries Market States and Outlook (2015-2028)
1.5 Market Dynamics and Development
1.5.1 Merger, Acquisition and New Investment
1.5.2 Market SWOT Analysis
1.5.3 Drivers
1.5.4 Limitations
1.5.5 Opportunities and Development Trends
1.6 Global Anti-Obesity Therapeutics Market Size Analysis from 2015 to 2028
1.6.1 Global Anti-Obesity Therapeutics Market Size Analysis from 2015 to 2028 by Consumption Volume
1.6.2 Global Anti-Obesity Therapeutics Market Size Analysis from 2015 to 2028 by Value
1.6.3 Global Anti-Obesity Therapeutics Price Trends Analysis from 2015 to 2028
2 Global Anti-Obesity Therapeutics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Anti-Obesity Therapeutics (Volume and Value) by Type
2.1.1 Global Anti-Obesity Therapeutics Consumption and Market Share by Type (2015-2020)
2.1.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Type (2015-2020)
2.2 Global Anti-Obesity Therapeutics (Volume and Value) by Application
2.2.1 Global Anti-Obesity Therapeutics Consumption and Market Share by Application (2015-2020)
2.2.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Application (2015-2020)
2.3 Global Anti-Obesity Therapeutics (Volume and Value) by Region
2.3.1 Global Anti-Obesity Therapeutics Consumption and Market Share by Region (2015-2020)
2.3.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Region (2015-2020)
3 United States Anti-Obesity Therapeutics Market Analysis
3.1 United States Anti-Obesity Therapeutics Consumption and Value Analysis
3.2 United States Anti-Obesity Therapeutics Consumption Volume by Type
3.3 United States Anti-Obesity Therapeutics Consumption Structure by Application
4 Europe Anti-Obesity Therapeutics Market Analysis
4.1 Europe Anti-Obesity Therapeutics Consumption and Value Analysis
4.2 Europe Anti-Obesity Therapeutics Consumption Volume by Type
4.3 Europe Anti-Obesity Therapeutics Consumption Structure by Application
4.4 Europe Anti-Obesity Therapeutics Consumption by Top Countries
4.4.1 Germany Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
4.4.2 UK Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
4.4.3 France Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
4.4.4 Italy Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
4.4.5 Spain Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
4.4.6 Poland Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
4.4.7 Russia Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
5 China Anti-Obesity Therapeutics Market Analysis
5.1 China Anti-Obesity Therapeutics Consumption and Value Analysis
5.2 China Anti-Obesity Therapeutics Consumption Volume by Type
5.3 China Anti-Obesity Therapeutics Consumption Structure by Application
6 Japan Anti-Obesity Therapeutics Market Analysis
6.1 Japan Anti-Obesity Therapeutics Consumption and Value Analysis
6.2 Japan Anti-Obesity Therapeutics Consumption Volume by Type
6.3 Japan Anti-Obesity Therapeutics Consumption Structure by Application
7 Southeast Asia Anti-Obesity Therapeutics Market Analysis
7.1 Southeast Asia Anti-Obesity Therapeutics Consumption and Value Analysis
7.2 Southeast Asia Anti-Obesity Therapeutics Consumption Volume by Type
7.3 Southeast Asia Anti-Obesity Therapeutics Consumption Structure by Application
7.4 Southeast Asia Anti-Obesity Therapeutics Consumption by Top Countries
7.4.1 Indonesia Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
7.4.2 Thailand Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
7.4.3 Philippines Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
7.4.4 Malaysia Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
7.4.5 Singapore Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
7.4.6 Vietnam Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
8 India Anti-Obesity Therapeutics Market Analysis
8.1 India Anti-Obesity Therapeutics Consumption and Value Analysis
8.2 India Anti-Obesity Therapeutics Consumption Volume by Type
8.3 India Anti-Obesity Therapeutics Consumption Structure by Application
9 Brazil Anti-Obesity Therapeutics Market Analysis
9.1 Brazil Anti-Obesity Therapeutics Consumption and Value Analysis
9.2 Brazil Anti-Obesity Therapeutics Consumption Volume by Type
9.3 Brazil Anti-Obesity Therapeutics Consumption Structure by Application
10 GCC Countries Anti-Obesity Therapeutics Market Analysis
10.1 GCC Countries Anti-Obesity Therapeutics Consumption and Value Analysis
10.2 GCC Countries Anti-Obesity Therapeutics Consumption Volume by Type
10.3 GCC Countries Anti-Obesity Therapeutics Consumption Structure by Application
10.4 GCC Countries Anti-Obesity Therapeutics Consumption Volume by Major Countries
10.4.1 Saudi Arabia Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
10.4.2 United Arab Emirates Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
10.4.3 Qatar Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
10.4.4 Bahrain Anti-Obesity Therapeutics Consumption Volume from 2015 to 2020
11 Manufacturers Profiles
11.1 Bristol-Myers Squibb
11.1.1 Business Overview
11.1.2 Products Analysis
11.1.3 Bristol-Myers Squibb Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin
11.1.4 Bristol-Myers Squibb Anti-Obesity Therapeutics Sales by Region
11.2 Vivus
11.2.1 Business Overview
11.2.2 Products Analysis
11.2.3 Vivus Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin
11.2.4 Vivus Anti-Obesity Therapeutics Sales by Region
11.3 BoehringerIngelheim GmbH
11.3.1 Business Overview
11.3.2 Products Analysis
11.3.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin
11.3.4 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales by Region
11.4 Shionogi USA
11.4.1 Business Overview
11.4.2 Products Analysis
11.4.3 Shionogi USA Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin
11.4.4 Shionogi USA Anti-Obesity Therapeutics Sales by Region
11.5 Pfizer
11.5.1 Business Overview
11.5.2 Products Analysis
11.5.3 Pfizer Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin
11.5.4 Pfizer Anti-Obesity Therapeutics Sales by Region
11.6 Novo Nordisk
11.6.1 Business Overview
11.6.2 Products Analysis
11.6.3 Novo Nordisk Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin
11.6.4 Novo Nordisk Anti-Obesity Therapeutics Sales by Region
11.7 Takeda Pharmaceutical
11.7.1 Business Overview
11.7.2 Products Analysis
11.7.3 Takeda Pharmaceutical Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin
11.7.4 Takeda Pharmaceutical Anti-Obesity Therapeutics Sales by Region
11.8 Alizyme
11.8.1 Business Overview
11.8.2 Products Analysis
11.8.3 Alizyme Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin
11.8.4 Alizyme Anti-Obesity Therapeutics Sales by Region
11.9 Rhythm Pharmaceuticals
11.9.1 Business Overview
11.9.2 Products Analysis
11.9.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin
11.9.4 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales by Region
11.10 Eisai Company
11.10.1 Business Overview
11.10.2 Products Analysis
11.10.3 Eisai Company Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin
11.10.4 Eisai Company Anti-Obesity Therapeutics Sales by Region
11.11 Norgine Pharmaceuticals Ltd.
11.11.1 Business Overview
11.11.2 Products Analysis
11.11.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin
11.11.4 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Sales by Region
11.12 Zafgen
11.12.1 Business Overview
11.12.2 Products Analysis
11.12.3 Zafgen Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin
11.12.4 Zafgen Anti-Obesity Therapeutics Sales by Region
11.13 FlaxoSithKline plc.
11.13.1 Business Overview
11.13.2 Products Analysis
11.13.3 FlaxoSithKline plc. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin
11.13.4 FlaxoSithKline plc. Anti-Obesity Therapeutics Sales by Region
13 Global Anti-Obesity Therapeutics Market Forecast (2020-2028)
13.1 Global Anti-Obesity Therapeutics Consumption Volume, Revenue and Price Forecast (2020-2028)
13.1.1 Global Anti-Obesity Therapeutics Consumption Volume and Growth Rate Forecast (2020-2028)
13.1.2 Global Anti-Obesity Therapeutics Value and Growth Rate Forecast (2020-2028)
13.1.3 Global Anti-Obesity Therapeutics Price and Trend Forecast (2020-2028)
13.2 Global Anti-Obesity Therapeutics Consumption Volume, Value and Growth Rate Forecast by Region (2020-2028)
13.2.1 Global Anti-Obesity Therapeutics Consumption Volume and Growth Rate Forecast by Region (2020-2028)
13.2.2 Global Anti-Obesity Therapeutics Value and Growth Rate Forecast by Region (2020-2028)
13.3 Global Anti-Obesity Therapeutics Consumption Volume, Revenue and Price Forecast by Type (2020-2028)
13.3.1 Global Anti-Obesity Therapeutics Consumption Forecast by Type (2020-2028)
13.3.2 Global Anti-Obesity Therapeutics Revenue Forecast by Type (2020-2028)
13.3.3 Global Anti-Obesity Therapeutics Price Forecast by Type (2020-2028)
13.4 Global Anti-Obesity Therapeutics Consumption Volume Forecast by Application (2020-2028)
14 Research Conclusions
15 Appendix
15.1 Methodology
15.2 Research Data Source
